Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis

Current therapy for leishmaniasis is unsatisfactory because parenteral antimonial salts and pentamidine are associated with significant toxicity and failure rates. We examined the efficacy of KY62, a new, water-soluble, polyene antifungal, against cutaneous infection with Leishmania amazonensis and...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Al-Abdely, Hail M., Graybill, John R., Bocanegra, Rosie, Najvar, Laura, Montalbo, Eleanor, Regen, Steven L., Melby, Peter C.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1998
Teme:	Experimental Therapeutics
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105886/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9756753/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.10.2542
Oznake:	Označite Brez oznak, prvi označite!